secwatch.observer — SEC 8-K summary
======================================

Issuer:     20/20 Biolabs, Inc. (AIDX)
CIK:        0001139685
Form:       8-K
Filed at:   2026-04-28T23:59:59+00:00
Accession:  0001213900-26-048257
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

20/20 Biolabs cuts warrant exercise price to $2.25, from $11.42/$8.00
---------------------------------------------------------------------

- On April 23, 2026, amended Streeterville warrants lowering exercise price to $2.25/share.
- Warrants cover 3,627,627 shares; prior prices were $11.42 and $8.00.
- Company retains right to terminate amendment within 90 days on 2 days' notice.
- Warrants issued in conjunction with $5M+ in convertible notes and Series E preferred.
- Reduction implies significant potential dilution for existing common shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1139685/000121390026048257/0001213900-26-048257-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1139685/000121390026048257/ea0287933-8k_2020bio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-048257

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer